Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12–13 Months of Age in Colombia and Peru

2016 ◽  
Vol 35 (10) ◽  
pp. 1140-1147 ◽  
Author(s):  
Pio López ◽  
Claudio F. Lanata ◽  
Betzana Zambrano ◽  
Margarita Cortés ◽  
Teresa Andrade ◽  
...  
Keyword(s):  
Yellow Fever ◽  
Vaccine Candidate ◽  
Yellow Fever Vaccine ◽  
Dengue Vaccine

scholarly journals Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia

2018 ◽  
Vol 37 (11) ◽  
pp. 1190-1191 ◽  
Author(s):  
Margarita Cortés ◽  
Pio López ◽  
Viviana Márquez ◽  
Carlos Cortes ◽  
Elizabeth Toro ◽  
...  
Keyword(s):  
Yellow Fever ◽  
Yellow Fever Vaccine ◽  
Dengue Vaccine

scholarly journals Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models

Vaccine ◽  
2021 ◽  
Author(s):  
Fabienne Piras-Douce ◽  
Franck Raynal ◽  
Alix Raquin ◽  
Yves Girerd-Chambaz ◽  
Sylviane Gautheron ◽  
...  
Keyword(s):  
Animal Models ◽  
Yellow Fever ◽  
Vaccine Candidate ◽  
Small Animal ◽  
Yellow Fever Vaccine ◽  
Next Generation ◽  
Small Animal Models

scholarly journals A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate

2019 ◽  
Vol 142 ◽  
pp. 334-343 ◽  
Author(s):  
Didier Clénet ◽  
Véronique Hourquet ◽  
Bertrand Woinet ◽  
Hervé Ponceblanc ◽  
Manuel Vangelisti
Keyword(s):  
Yellow Fever ◽  
Vaccine Candidate ◽  
Yellow Fever Vaccine ◽  
Proof Of Concept ◽  
Freeze Dried

Dengue and Zika Virus Infections Are Enhanced by Live Attenuated Dengue Vaccine but Not by Recombinant DSV4 Vaccine Candidate in Mouse Models

2020 ◽  
Author(s):  
Rahul Shukla ◽  
Julia A. Brown ◽  
Hemalatha Beesetti ◽  
Richa Ahuja ◽  
Viswanathan Ramasamy ◽  
...  
Keyword(s):  
Mouse Models ◽  
Zika Virus ◽  
Vaccine Candidate ◽  
Virus Infections ◽  
Dengue Vaccine

Corneal Graft Rejection after Yellow Fever Vaccine: A Case Report

2021 ◽  
pp. 1-4
Author(s):  
Roberto Vignapiano ◽  
Lidia Vicchio ◽  
Eleonora Favuzza ◽  
Michela Cennamo ◽  
Rita Mencucci
Keyword(s):  
Case Report ◽  
Yellow Fever ◽  
Graft Rejection ◽  
Corneal Graft ◽  
Yellow Fever Vaccine ◽  
Corneal Graft Rejection

Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?

2021 ◽  
pp. 135245852110063
Author(s):  
Caroline Papeix ◽  
Julie Mazoyer ◽  
Elisabeth Maillart ◽  
Caroline Bensa ◽  
Anne-Laure Dubessy ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cohort Study ◽  
Yellow Fever ◽  
Yellow Fever Vaccine ◽  
Relapsing Remitting ◽  
Annualized Relapse Rate ◽  
National Cohort ◽  
First Relapse ◽  
Yellow Fever Vaccination ◽  
Relapsing Remitting Multiple Sclerosis

Background: Yellow fever vaccine (YFV) is not advised for multiple sclerosis (MS) patients because of the potential risk of post-vaccine relapses. Objective: To assess the risk of relapsing-remitting multiple sclerosis (RR-MS) worsening after YFV. Methods: Non-interventional observational retrospective, exposed/non-exposed cohort study nested in the French national cohort including MS. Results: 128 RR-MS were included. The 1-year annualized relapse rate (ARR) following YFV did not differ between exposed: 0.219 (0.420) and non-exposed subjects: 0.208 (0.521) ( p = 0.92). Time to first relapse was not different between groups (adjusted hazard ratio (HR) = 1.33; 95% confidence interval (CI) = 0.53–3.30, p = 0.54). Conclusion: These results suggest that YFV does not worsen the course of RR-MS.

Sign in / Sign up

Export Citation Format

Share Document